services and the contribution of the social and behavioural sciences (economics, anthropology, sociology and so on) are neglected fields. This is increasingly being recognized and addressed for specific diseases, but a more systematic approach is needed, which may benefit the entire health sector. Such research is critical in linking basic research to healthcare delivery, and in obtaining the participation and support of the people at whom new interventions are targeted.
For the Bill Gates billions to make a difference, a robust and efficient health system is needed in the countries where he hopes to have an impact. Without this, the multitude of new vaccines and drugs developed will have a negligible effect in reducing disease burdens.
To leaders from the public, private and non-governmental sectors, the scientific community and the funders of health research to develop an action plan to address the key challenges of translating knowledge into health policy.
You referred to PPPs -public-private partnerships -as a successful means of bringing malaria drugs to market. No arguments there. But PPP could also stand for "publications, patents and professorships" -the mindset of many scientists in basic research.
It is my hope that the philanthropy of Bill Gates, through appropriate funding of research, will help to nurture another PPP mindset of "policy, practice and people". He should put more of his money into research that will ensure that his laudable investments to date will have a real impact in improving the health and well-being of poor populations in the developing world.
Tikki Pang

Research Policy and Cooperation, World Health Organization, Avenue Appia, 1211 Geneva 27, Switzerland
Open access: the JCI has already shown it works Sir -There has been much media attention surrounding the launch of the new open-access journal, PLoS Biology (see, for example, Nature 425, 554-555; 2003) , which many scientists like myself hope will prove to be a success. However, some of the claims of originality for this venture are not warranted. The proposed model, in which authors pay the costs of free electronic access, has already been tested successfully by an existing highprofile periodical, the Journal of Clinical Investigation (JCI). Since the JCI went online (www.jci.org) in 1996, its content has remained completely free to everyone, with no barrier of any kind (J. B. Hawley J. Clin. Invest. 112, 968-969; 2003) . This fits with the philosophy of its parent organization, the American Society for Clinical Investigation (ASCI).
Although the publishing and financial models of the JCI are not exactly the same as those of PLoS Biology, the only major difference appears to be that the ASCI holds copyright to articles. However, this is meant primarily to ensure the long-term integrity of the published work, and authors are not prevented from using the electronic version in any way that would advance the cause of science.
Overall, the positive experience of the JCI with author-paid electronic free access augurs well for the future of PLoS Biology, and for other journals that may choose to take this path.
Of course, the same model may not apply easily to journals such as Nature, which also have to cover the costs of extensive front matter and general science policy and news reporting, thus serving a somewhat different role in scientific publishing.
Ajit Varki
Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0687, USA Dr Varki has previously served as editorin-chief of the JCI and president of the ASCI -Editor, Correspondence
Aircraft give a new view of jellyfish behaviour
Sir -In her recent News Feature "Close encounters of the jelly kind" (Nature 426, 12-15; 2003) Carina Dennis describes the use of submersibles to catalogue jellyfish in the ocean. However, it is not just in the inaccessible deep ocean that technology is helping to improve our knowledge of jellyfish: the same applies to coastal areas. For example, scientists have struggled for more than half a century to record the distribution and abundance of giant Rhizostoma jellyfish in British and Irish waters. Today, low-flying aircraft are being used to survey wide areas.
This method revealed huge numbers of Rhizostoma -roughly one per square metre -in Carmarthen and Tremadoc bays in Wales from April to November this year. What drives these jellyfish to aggregate in these two large bays is unknown. However, both of these Welsh bays are known hotspots for sightings of jelly-feeding leatherback turtles, suggesting that some top predators are able to take advantage of this annual jelly-feast.
